Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

CUSIP: 83086J200

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
33,945,050
Total 13F shares
25,208,315
Share change
-509,607
Total reported value
$71,310,457
Put/Call ratio
0%
Price per share
$2.83
Number of holders
70
Value change
-$3,219,919
Number of buys
37
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 83086J200?
CUSIP 83086J200 identifies SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q4 2024

As of 31 Dec 2024, Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,208,315 shares. The largest 10 holders included 5AM Venture Management, LLC, Versant Venture Management, LLC, SPHERA FUNDS MANAGEMENT LTD., BAKER BROS. ADVISORS LP, Schonfeld Strategic Advisors LLC, BlackRock, Inc., Altium Capital Management LLC, VANGUARD GROUP INC, BRAIDWELL LP, and Ensign Peak Advisors, Inc. This page lists 70 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.